To test this, we reduced the expression levels of survivin in non-stem glioma cells by introducing the same siRNAs we used for glioma stem cells and found that non-stem glioma cells did not undergo cell death despite reduced levels of survivin expression (Figure 9A,B). This evidence concerns the gene BIRC5 and central nervous system cancer.